2009 News | Events | Industry Updates
In Mar-08 the EEDA awarded Selcia a 1 year R&D grant of up to £94k funding a project to evaluate anti-inflammatory activity of SEL-100130. In Feb-09 the grant was extended for 6 months and a patent application was filed in Sep-09.
Selcia Ltd, a leading 14C custom radiolabelling provider and drug discovery company this week launched their new Fragment Screening Platform and unveiled their new brand as part of ambitious international expansion plans.
Selcia is exhibiting once more at this year's CIR AgChem Forum, Barcelona, 23-24 September 2009.
Selcia is exhibiting at this year's Pharma ChemOutsourcing Conference and Exhibition at the Ocean Place Resort, Long Branch, New Jersey, 14-16 September 2009.
Selcia will be presenting at the 10th International Symposium of the International Isotope Society in Chicago, 14-18 June 2009.